LONDON, Nov 27 (Reuters) - AstraZeneca Plc said on Monday it would work with the U.S. Food and Drug Administration to resolve a problem over promotional material for its drug Seroquel after receiving a warning from the agency.
LONDON, Nov 27 (Reuters) - AstraZeneca Plc said on Monday it would work with the U.S. Food and Drug Administration to resolve a problem over promotional material for its drug Seroquel after receiving a warning from the agency.
